SPRY — ARS PHARMACEUTICALS

Ownership history in SR ONE CAPITAL MANAGEMENT, LP  ·  13 quarters on record

This page tracks every 13F SEC filing in which SR ONE CAPITAL MANAGEMENT, LP reported a position in ARS PHARMACEUTICALS (SPRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
15.18% (2025 Q2)
Avg. % of fund
10.26%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 4,012,903 — 0% 6.62% $46.8M $11.65
2025 Q3 UNCHANGED 4,012,903 — 0% 5.83% $40.3M $10.05
2025 Q2 UNCHANGED 4,012,903 — 0% 15.18% $70.0M $17.45
2025 Q1 UNCHANGED 4,012,903 — 0% 12.97% $50.5M $12.58
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SPRY price (monthly, adj. close)

Other funds also holding SPRY

As of 2025 Q4 — sorted by position size

Tyro Capital Management LLC 4.16% ORBIMED ADVISORS LLC 3Y 7Y 1.97% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.3% Casdin Capital, LLC 3Y 7Y 1.16% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.12% Lisanti Capital Growth, LLC 3Y 7Y 1.09% INVESTMENT MANAGEMENT ASSOCIATES INC /ADV 3Y 1.0% Rubric Capital Management LP 3Y 7Y 0.86% LEVIN CAPITAL STRATEGIES, L.P. 3Y 7Y 0.75% DAFNA Capital Management LLC 3Y 7Y 0.51%
← Back to SR ONE CAPITAL MANAGEMENT, LP Holdings